Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
LORZENSAAL CHAMDorfplatz 3 | Cham
Switzerland
LORZENSAAL CHAMDorfplatz 3 | Cham | Switzerland
23-24 April 2020
PREL
IMIN
ARY
PRO
GRAM
FERTILITYIN SAFE:FIRST GEA IVFCONGRESS
INFO & UPDATE: www.fertilityinsafe2020-gea.com
Organizer GEA IVF AGReproduktionsmedizin Labor Hirslanden Ärztezentrum LorzeDorfplatz 1 - 6330 Cham Switzerlandwww.gea-ivf.swiss
Scientific CommitteeMarkus BleichenbacherGraziella BraconeRaffaella FabbriMartine Nijs
Scientific SecretariatGraziella [email protected]
FERTILITYIN SAFE:FIRST GEA IVFCONGRESSLORZENSAAL CHAMDorfplatz 3 | ChamSwitzerland23-24 April 2020
INFO & UPDATE
THE CONGRESSWILL DISCUSS:• Recent advances and
current challenges in fertility preservation for women, men and children, as well as future trend in this field
• Management of oncological patients, optimizing the connection between oncologist and IVF center
• Improvement of patient care through psychological and social support
23rd
Apr
il 20
20
12:00 Registration and Welcome lunch
13:00 Director Jonas Zollinger
13:15 Director Markus Bleichenbacher
Oncological treatment and its effect on fertility: what do we know? Chairman: Sabine Steimann
13:30 Massimo Abate Cancer survivorship among children,
adolescents and young adults: update and new perspectives
14:00 Andreas Günthert Breast and gynecological cancers:
incidence, survival and fertility preservation
14:30 Norah Spears The direct effect of chemotherapy
drugs on the ovary and testis: a research perspective
15:0015:30 Coffee break
What are the options that women have for preserving their fertility?
Chairman: Graziella Bracone
15:30 Ana Cobo Oocyte cryopreservation: state of art
16:00 Raffella Fabbri Ovarian tissue cryopreservation - 20 years of experience in: state of art in Italy
Options available for men Chairman: Herman Tournaye
16:30 Allan Pacey Fertility preservation options for
adult men with cancer
Psychological and social prospective
Chairman: Raffaella Fabbri
17:00 Serena Galliera Counselling for oncological and ART patients
17:30 Serena Galliera An interview with patient live birth after ovarian tissue
reimplantation: patient’s story
20:00 Social dinner HOTEL CHÂTEAU GÜTSCH
Kanonenstrasse, Luzern
1SECTION
2SECTION
3SECTION
4SECTION
New challenges Part 2 Chairman: Martine Nijs
13:30 Lodovico Parmegiani Vitrification and long term storage
of oocytes, embryos and tissues: is it safe?14:00 Christiani A. Amorim Ovarian Tissue Cryopreservation:
slow freezing or vitrification?14:30 Evelyn Telfer Lab grown eggs from ovarian tissue: next steps towards clinical application
Endocrinological point of view Chairman: Michael Von Wolff
15:00 Roberto Marci The aftermath of female cancer
survivor: endocrinological management and follow up
15:30 Jacques Donnez OTT as hormonal replacement
therapy after menopause
16:0016:30 Coffee break
Fertility preservation and IVF Chairman: Marc Van den Bergh
16:30 Michael Von Wolff Ovarian stimulation for freezing
of oocytes and after tissue transplantation: art of the ART?
17:00 Graziella Bracone Setting up an ART laboratory for fertility preservation: what it all involves
17:30 Closing speech: 17:45 Markus Bleichenbacher
24th
Apr
il 20
20
Fertility preservation for children Chairman: Norah Spears 8:00 Herman Tournaye Fertility preservation for pre-pubertal boys: where are we in 2020? 8:30 Catherine Poirot Fertility preservation for pre-pubertal girls with cancer
New challenges Part 1 Chairman: Thomas W.F Wilken
9:00 Ellen Goossens Future options for fertility
restoration using cryopreserved spermatogonial stem cells
9:30 Marie-Madeleine Dolmans How to improve vascularization in ovarian tissue transplantation: the use of adipose tissue derived
stem cells 10:00 Christiani A. Amorim Development of a transplantable
artificial ovary
10:3011:00 Coffee break
Ovarian tissue reimplantation techniques
Chairman: Andreas Günthert 11:00 Jacques Donnez Ovarian Tissue Transplantation:
techniques and results, where we are in 2020?
11:30 Kutluk Oktay Evolution of ovarian auto-transplantation from
laparoscopic to robotic approaches since our first success in 1999
12:00 Marie-Madeleine Dolmans The risk of reimplanting malignant
cells
12:3013:30 Lunch break
9SECTION
10SECTION7
SECTION
8SECTION
25th April 2020 | Social Event Lake Lucerne and Mount Rigi
5SECTION
6SECTION
CHAIRPERSONS & SPEAKERSMassimo Abate AORN Santobono-Pausilipon of Naples, Italy
Christiani A. Amorim Catholic University of Louvain, Belgium
Markus Bleichenbacher GEA IVF AG, Switzerland
Graziella Bracone GEA IVF AG, Switzerland
Ana Cobo IVI, Spain
Marie-Madeleine Dolmans Catholic University of Louvain, Belgium
Jacques Donnez Catholic University of Louvain, Belgium
Raffella Fabbri University of Bologna, Italy
Serena Galliera Studio di Psicoterapia Mirabello , Italy
Ellen Goossens Vrije University of Brussel, Belgium
Andreas Günthert Gyn Zentrum, Switzerland
Roberto Marci Hirslanden Clinique La Colline, Switzerland
Martine Nijs Cooper Surgical Fertility and Genomic Solutions, Denmark
Kutluk Oktay Yale University School of Medicine, USA
Allan Pacey University of Sheffield, United Kingdom
Lodovico Parmegiani GynePro-NextClinics, Italy
Catherine Poirot Groupe Hospitalier Pitié-Salpêtrière, France
Norah Spears University of Edinburgh, United Kingdom
Sabine Steimann Hirslanden Klinik St. Anna, Switzerland
Evelyn Telfer University of Edinburgh, United Kingdom
Herman Tournaye Vrije University Brussel, Belgium
Marc Van den Bergh Quartec GmbH, Switzerland
Michael Von Wolff Bern University Hospital, Switzerland
Thomas W.F Wilken GEA IVF AG, Switzerland
Jonas Zollinger Hirslanden AndreasKlinik, Switzerland
VenueLORZENSAAL CHAMDorfplatz 3 | Cham | SwitzerlandFurther information to reach the Venue:www.lorzensaal.ch/en/metamenu/arrival
Lorzensaal ChamHotel LorzeEinkaufszentrum NeudorfCoopGemeindehaus MadelhofAndreas Klinik (Hirslanden)KirkeKreisel
ORGANIZING SECRETARIATDolphin OrganizationVia M. D’Azeglio, 57 40124 Bologna BO Italy Phone: +39 051 3547676 [email protected] www.dolphinorganization.com [email protected] http://www.fertilityinsafe2020-gea.com/ REGISTRATIONThe number of participants will be limited to 180 people.Priority shall be given according to the date of receipt of the registration form. REGISTRATION FEE until 30.11.2019Early Bird Congress Fee 460,00 EURO Congress Fee 510,00 EURO The registration fee includes: attendance at scientific sessions, welcome lunch, coffee breaks, lunch, social dinner, CPD accreditation
HOw TO REGISTERPlease Register on-line at:www.fertilityinsafe2020-gea.com
SPONSOR
PAYMENTCredit Card (only on-line registration)Bank Transfer toDolphin Organization Account nr.: 977972IBAN Code: IT60V0538702412000000977972SWIFT/BIC Code: BPM0IT22REFERENCE: NAME PARTICIPANT + FERTILITYINSAFE-GEAIVFCONGRESS2020Bank Transfer must be accompanied by Registration Form Please notice that your registration will not be processed until the full registration fee payment is received
PAYMENT, CANCELLATION AND REFUND RULESMore info: www.fertilityinsafe2020-gea.com
HOTEL RESERVATIONA limited number of rooms has been optioned at discounted prices. For any reservations, please [email protected] Hotel reserves the right to confirm the availability of the rooms at the time of booking.
GENERAL INFORMATION
ZUGERSEEVILLETTEPARK
LORZE
LUZER
NERSTR
ASSEHÜNENBERGERSTRASSE
SINSERSTRASSE KNON
AUER
STRA
SSE
SEESTRASSE
ZUGERSTRASSE
6
1
5
7
3
AUTOBAHNZÜRICH UND LUZERN
2
4
1 Lorzensaal Cham
4 Coop
2 Hotel Lorze2 Einkaufszentrum Neudorf3
5 Gemeindehaus Mandelhof6 Andreas Klinik (Hirslanden)7 Kirche
Kreisel
ZugCham
Luzern
Zürich
Kloten
ZUGERSEEVILLETTEPARK
LORZE
LUZER
NERSTR
ASSEHÜNENBERGERSTRASSE
SINSERSTRASSE KNON
AUER
STRA
SSE
SEESTRASSE
ZUGERSTRASSE
6
1
5
7
3
AUTOBAHNZÜRICH UND LUZERN
2
4
ZugCham
Luzern
Zürich
Kloten
SBB